Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.35 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 5/20 | 0.35 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.34 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17634633 | 0.93 | PRKDC (0.48) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355499 | 0.92 | PRKDC (0.41) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL20373227 | 0.91 | PRKDC (0.40) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL20373566 | 0.91 | PRKDC (0.40) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355279 | 0.89 | PRKDC (0.43) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19905174 | 0.88 | PRKDC (0.42) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355142 | 0.87 | RIPK1 (0.37) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355505 | 0.87 | PRKDC (0.40) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355655 | 0.87 | PRKDC (0.41) | PRKDCCYP1A2CYP3A4CYP2D6CLK4 | |
| SCHEMBL19355597 | 0.87 | PRKDC (0.41) | PRKDCRIPK1SLC40A1ALKHDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170258789-A1 | DNA-PK INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2017-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170258789-A1 | DNA-PK INHIBITORS | POLK, DTYMK, DCK | PRKDC 33/4885CYP1A2 2215/4885CYP3A4 1759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.